JP2023524132A5 - - Google Patents

Info

Publication number
JP2023524132A5
JP2023524132A5 JP2022567285A JP2022567285A JP2023524132A5 JP 2023524132 A5 JP2023524132 A5 JP 2023524132A5 JP 2022567285 A JP2022567285 A JP 2022567285A JP 2022567285 A JP2022567285 A JP 2022567285A JP 2023524132 A5 JP2023524132 A5 JP 2023524132A5
Authority
JP
Japan
Prior art keywords
car
nucleic acid
acid sequence
sequence
spacer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022567285A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023524132A (ja
Filing date
Publication date
Priority claimed from GBGB2006820.1A external-priority patent/GB202006820D0/en
Application filed filed Critical
Publication of JP2023524132A publication Critical patent/JP2023524132A/ja
Publication of JP2023524132A5 publication Critical patent/JP2023524132A5/ja
Pending legal-status Critical Current

Links

JP2022567285A 2020-05-07 2021-05-06 細胞 Pending JP2023524132A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2006820.1 2020-05-07
GBGB2006820.1A GB202006820D0 (en) 2020-05-07 2020-05-07 Cell
PCT/GB2021/051099 WO2021224629A1 (en) 2020-05-07 2021-05-06 Cell

Publications (2)

Publication Number Publication Date
JP2023524132A JP2023524132A (ja) 2023-06-08
JP2023524132A5 true JP2023524132A5 (cg-RX-API-DMAC7.html) 2024-03-15

Family

ID=71134856

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022567285A Pending JP2023524132A (ja) 2020-05-07 2021-05-06 細胞

Country Status (14)

Country Link
US (1) US20240408134A1 (cg-RX-API-DMAC7.html)
EP (1) EP4146259A1 (cg-RX-API-DMAC7.html)
JP (1) JP2023524132A (cg-RX-API-DMAC7.html)
KR (1) KR20230008153A (cg-RX-API-DMAC7.html)
CN (1) CN115551544A (cg-RX-API-DMAC7.html)
AU (1) AU2021266432A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022021176A2 (cg-RX-API-DMAC7.html)
CA (1) CA3177773A1 (cg-RX-API-DMAC7.html)
CL (2) CL2022003060A1 (cg-RX-API-DMAC7.html)
GB (1) GB202006820D0 (cg-RX-API-DMAC7.html)
IL (1) IL297901A (cg-RX-API-DMAC7.html)
MX (1) MX2022013933A (cg-RX-API-DMAC7.html)
WO (1) WO2021224629A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202211411B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201503742D0 (en) * 2015-03-05 2015-04-22 Ucl Business Plc Chimeric antigen receptor
WO2019220109A1 (en) 2018-05-15 2019-11-21 Autolus Limited Chimeric antigen receptor
WO2022254337A1 (en) * 2021-06-01 2022-12-08 Novartis Ag Cd19 and cd22 chimeric antigen receptors and uses thereof
EP4504221A4 (en) * 2022-03-22 2026-02-25 Celyntra Therapeutics Sa Compositions and methods for generating cells with reduced immunogenicity
MX2025014738A (es) * 2023-06-09 2026-02-03 Antengene Biologics Ltd Nuevos anticuerpos dirigidos a cd3 y otra diana y usos de los mismos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908807D0 (en) 1999-04-16 1999-06-09 Celltech Therapeutics Ltd Synthetic signalling molecules
JP2002541845A (ja) 1999-04-16 2002-12-10 セルテック セラピューティックス リミテッド 合成膜貫通成分
RS63601B1 (sr) * 2014-10-09 2022-10-31 Univ Yamaguchi Vektor ekspresije car i t ćelije koje eksprimiraju car
HRP20240357T1 (hr) * 2014-12-24 2024-06-07 Autolus Limited Stanica
GB201504840D0 (en) 2015-03-23 2015-05-06 Ucl Business Plc Chimeric antigen receptor
GB201509413D0 (en) 2015-06-01 2015-07-15 Ucl Business Plc Fusion protein
GB201620070D0 (en) * 2016-11-28 2017-01-11 Autolus Ltd Signal transduction modifying protein
KR102879284B1 (ko) * 2018-08-29 2025-10-31 난징 레전드 바이오테크 씨오., 엘티디. 항-메소텔린 키메라 항원 수용체(car) 작제물 및 이의 용도
EP3934666A1 (en) * 2019-03-08 2022-01-12 Autolus Limited Compositions and methods comprising engineered chimeric antigen receptor and modulator of car

Similar Documents

Publication Publication Date Title
JP7578938B2 (ja) B7-h3に対するモノクローナル抗体および細胞治療におけるその使用
JP7642010B2 (ja) 改良された抗原結合受容体
TWI817302B (zh) 改良的雙特異性多肽分子
JP2022109953A5 (cg-RX-API-DMAC7.html)
US11180553B2 (en) Chimeric antigen receptor
JP2023139070A5 (cg-RX-API-DMAC7.html)
RU2017121892A (ru) Клетка
CN112912401B (zh) 抗-l1细胞粘附分子抗体或其抗原结合片段及包含其的嵌合抗原受体
JP2024532485A5 (cg-RX-API-DMAC7.html)
JP2018501794A5 (cg-RX-API-DMAC7.html)
JP2022542543A5 (cg-RX-API-DMAC7.html)
JP2019535262A5 (cg-RX-API-DMAC7.html)
CN110121505A (zh) 嵌合抗原受体和表达其的自然杀伤细胞
IL252621B2 (en) Chimeric antigen receptors targeting g-protein coupled receptor and uses thereof
CN113195542A (zh) Cd30-结合部分、嵌合抗原受体及其用途
CN109789164B (zh) 具有gitr胞内结构域作为共刺激结构域的嵌合抗原受体
JP2022542559A5 (cg-RX-API-DMAC7.html)
EP3783026A1 (en) Switch molecule and switchable chimeric antigen receptor
JP2024516308A5 (cg-RX-API-DMAC7.html)
JP2024504162A5 (cg-RX-API-DMAC7.html)
KR20230008153A (ko) 세포
KR20210143097A (ko) Cd22에 특이적인 항체 및 이의 용도
JP2024534783A5 (cg-RX-API-DMAC7.html)
CN114286691B (zh) Cs1-抗体和抗cs1-car-t细胞
KR20210143096A (ko) Cd22에 특이적인 항체 및 이의 용도